Veerle Melotte

3.8k total citations · 1 hit paper
53 papers, 2.4k citations indexed

About

Veerle Melotte is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Veerle Melotte has authored 53 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 15 papers in Surgery and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Veerle Melotte's work include Epigenetics and DNA Methylation (20 papers), Genetic factors in colorectal cancer (11 papers) and Colorectal Cancer Screening and Detection (7 papers). Veerle Melotte is often cited by papers focused on Epigenetics and DNA Methylation (20 papers), Genetic factors in colorectal cancer (11 papers) and Colorectal Cancer Screening and Detection (7 papers). Veerle Melotte collaborates with scholars based in Netherlands, United States and Belgium. Veerle Melotte's co-authors include Manon van Engeland, Wim Van Criekinge, James G. Herman, Kim M. Smits, Alexander Koch, Adriaan P. de Bruı̈ne, Sophie C. Joosten, Muriel X.G. Draht, Tim De Meyer and Leander Van Neste and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Scientific Reports.

In The Last Decade

Veerle Melotte

52 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of DNA methylation in cancer: location revisited

2018 491 citations Alexander Koch, Sophie C. Joosten et al. profile →

Peers

Countries citing papers authored by Veerle Melotte

Since Specialization

Citations

This map shows the geographic impact of Veerle Melotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veerle Melotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veerle Melotte more than expected).

Fields of papers citing papers by Veerle Melotte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veerle Melotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veerle Melotte. The network helps show where Veerle Melotte may publish in the future.

Co-authorship network of co-authors of Veerle Melotte

This figure shows the co-authorship network connecting the top 25 collaborators of Veerle Melotte. A scholar is included among the top collaborators of Veerle Melotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veerle Melotte. Veerle Melotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gastrointestinal Dysfunction and Low‐Grade Inflammation Associate With Enteric Neuronal Amyloid‐β in a Model for Amyloid Pathology 2025 ·Neurogastroenterology & Motility ·(unknown), (unknown), (unknown), Marion J. Gijbels, Bert Brône, Ilse Dewachter, Veerle Melotte, Werend Boesmans	1
2	Neuronal Distribution in Colorectal Cancer: Associations With Clinicopathological Parameters and Survival 2024 ·Modern Pathology ·(unknown), (unknown), (unknown), (unknown), Kristien Wouters, (unknown), (unknown), (unknown), Iryna Samarska, Matty P. Weijenberg, Piet A. van den Brandt, Manon van Engeland, Marion J. Gijbels, Werend Boesmans, Kim M. Smits, Veerle Melotte	6
3	Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trial 2023 ·British Journal of Cancer ·(unknown), Young‐Woo Kim, (unknown), (unknown), Lindsay C. Hewitt, Andrew F. Irvine, (unknown), (unknown), (unknown), Gregorio E. Fazzi, Shahab Jolani, Veerle Melotte, Derek Magee, Myeong‐Cherl Kook, Hyunki Kim, Rupert Langer, Jae‐Ho Cheong, Heike I. Grabsch	7
4	An optimization and refinement of the whole‐gut transit assay in mice 2023 ·Neurogastroenterology & Motility ·(unknown), (unknown), (unknown), Werend Boesmans, Ramon Langen, Veerle Melotte	2
5	Unbiased characterization of the larval zebrafish enteric nervous system at a single cell transcriptomic level 2023 ·iScience ·Laura E. Kuil, (unknown), (unknown), Eric M. Bindels, (unknown), (unknown), Robert M.W. Hofstra, Iain T. Shepherd, Veerle Melotte, Maria M. Alves	9
6	Nerves in gastrointestinal cancer: from mechanism to modulations 2022 ·Nature Reviews Gastroenterology & Hepatology ·Nathalie Vaes, (unknown), Werend Boesmans, Maria M. Alves, Veerle Melotte	35
7	Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC 2021 ·Clinical Epigenetics ·(unknown), (unknown), Alexander Koch, Muriel X.G. Draht, (unknown), Kristien Wouters, Nathalie Vaes, Tim De Meyer, Beatriz Carvalho, Gerrit A. Meijer, James G. Herman, Kim M. Smits, Manon van Engeland, Veerle Melotte	25
8	ATG12 deficiency results in intracellular glutamine depletion, abrogation of tumor hypoxia and a favorable prognosis in cancer 2021 ·Autophagy ·Tom G. Keulers, Alexander Koch, Marike W. van Gisbergen, (unknown), Marijke I. Zonneveld, Monique C. de Jong, Kim G.M. Savelkouls, (unknown), Johan Bussink, Veerle Melotte, Kasper M.A. Rouschop	24
9	The gut brain in a dish: Murine primary enteric nervous system cell cultures 2021 ·Neurogastroenterology & Motility ·(unknown), (unknown), (unknown), Ana Carina Bon‐Frauches, Werend Boesmans, Veerle Melotte	9
10	The enteric nervous system in gastrointestinal disease etiology 2021 ·Cellular and Molecular Life Sciences ·(unknown), Ana Carina Bon‐Frauches, Dániel Keszthelyi, Veerle Melotte, Werend Boesmans	87
11	Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review 2018 ·Clinical Epigenetics ·Muriel X.G. Draht, (unknown), Alexander Koch, Heike I. Grabsch, Matty P. Weijenberg, Manon van Engeland, Veerle Melotte, Kim M. Smits	34
12	NDRG 4, an early detection marker for colorectal cancer, is specifically expressed in enteric neurons 2017 ·Neurogastroenterology & Motility ·Nathalie Vaes, Marjolein H.F.M. Lentjes, Marion J. Gijbels, (unknown), Kathleen L.J. Daenen, Werend Boesmans, Kristien Wouters, (unknown), Xiaomei Qu, (unknown), Bart P. F. Rutten, (unknown), Keith A. Sharkey, Robert M.W. Hofstra, Manon van Engeland, Pieter Vanden Berghe, Veerle Melotte	9
13	A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients 2016 ·Clinical Cancer Research ·Iris J.H. van Vlodrop, Sophie C. Joosten, Tim De Meyer, Kim M. Smits, Leander Van Neste, Veerle Melotte, Marcella Baldewijns, Leo J. Schouten, Piet A. van den Brandt, Jana Jeschke, Joo Mi Yi, Kornel E. Schuebel, Nita Ahuja, James G. Herman, Maureen J.B. Aarts, Fred T. Bosman, Wim Van Criekinge, Manon van Engeland	44
14	Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome 2016 ·Clinical Epigenetics ·Muriel X.G. Draht, Kim M. Smits, Valérie Jooste, (unknown), (unknown), (unknown), Caroline Chapusot, Matty P. Weijenberg, Manon van Engeland, Veerle Melotte	19
15	The emerging role of GATA transcription factors in development and disease 2016 ·Expert Reviews in Molecular Medicine ·Marjolein H.F.M. Lentjes, Hanneke E.C. Niessen, Yoshimitsu Akiyama, Adriaan P. de Bruı̈ne, Veerle Melotte, Manon van Engeland	171
16	KRAS, BRAF and gastric cancer 2015 ·Research Publications (Maastricht University) ·Lindsay C. Hewitt, Gordon Hutchins, Veerle Melotte, Yuichi Saito, Heike I. Grabsch	5
17	CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer 2014 ·Clinical Cancer Research ·Arjen H.G. Cleven, Sarah Derks, Muriel X.G. Draht, Kim M. Smits, Veerle Melotte, Leander Van Neste, (unknown), Valérie Jooste, Caroline Chapusot, Matty P. Weijenberg, James G. Herman, Adriaan P. de Bruı̈ne, Manon van Engeland	30
18	Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 Are Promising Markers for the Detection of Colorectal Cancer in Blood 2014 ·Cancer Prevention Research ·Veerle Melotte, Joo Mi Yi, Marjolein H.F.M. Lentjes, Kim M. Smits, Leander Van Neste, Hanneke E.C. Niessen, Kristien Wouters, Joost Louwagie, Kornel E. Schuebel, James G. Herman, Stephen B. Baylin, Wim Van Criekinge, Gerrit A. Meijer, Nita Ahuja, Manon van Engeland	31
19	DNA Methylation of Phosphatase and Actin Regulator 3 Detects Colorectal Cancer in Stool and Complements FIT 2011 ·Cancer Prevention Research ·Linda J.W. Bosch, Frank A. Oort, Maarten Neerincx, Carolina A.J. Khalid-de Bakker, Jochim S. Terhaar sive Droste, Veerle Melotte, Daisy Jonkers, Ad Masclee, Sandra Mongera, Madeleine Grooteclaes, Joost Louwagie, Wim Van Criekinge, Veerle M.H. Coupé, Chris J. Mulder, Manon van Engeland, Beatriz Carvalho, Gerrit A. Meijer	45
20	Identification of Epigenetically Silenced Genes in Tumor Endothelial Cells 2007 ·Cancer Research ·Debby M.E.I. Hellebrekers, Veerle Melotte, Emmanuelle Viré, Elise Langenkamp, Grietje Molema, François Fuks, James G. Herman, Wim Van Criekinge, Arjan W. Griffioen, Manon van Engeland	113

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact